FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/12/038613 [Registered on: 14/12/2021] Trial Registered Prospectively
Last Modified On: 13/12/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Process of Care Changes 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Early Versus Late Feeding in Preterm neonates with abnormal flow study on antenatal ultrasound scan 
Scientific Title of Study   Early Versus Late Feeding in Preterm neonates with Absent or Reversed End Diastolic Flow on Antenatal Umbilical Doppler study”: A Randomized Controlled Trial 
Trial Acronym  ELFeeD 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Alpana Utture 
Designation  senior consultant 
Affiliation  Bai Jerbai Wadia HLospital for Children 
Address  Division of neonatology, 2nd floor, Bai Jerbai Wadia Hospital for Children, Acharya Donde marg , Parel, Mumbai
Division of neonatology, 2nd floor, Bai Jerbai Wadia hospital for Children,Acharya Donde marg , Parel, Mumbai
Mumbai
MAHARASHTRA
400012
India 
Phone  9820042059  
Fax    
Email  utture.alpana@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Astha Panghal 
Designation  DNB 
Affiliation  Bai Jerbai Wadia Hospital for Children 
Address  Division of neonatology, 2nd floor,Bai Jerbai Wadia hospital for Children, Acharya Donde marg , Parel, Mumbai
Division of Neonatology, 2nd floor, Bai Jerbai Wadia HLospital for Children, Acharya Donde marg , Parel, Mumbai
Mumbai
MAHARASHTRA
400012
India 
Phone  9654015228  
Fax    
Email  asthapanghal@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Alpana Utture 
Designation  senior consultant 
Affiliation  Bai Jerbai Wadia HLospital for Children 
Address  Division of neonatology, 2nd floor, Bai Jerbai Wadia Hospital for Children, Acharya Donde marg , Parel, Mumbai
Division of neonatology, 2nd floor, Bai Jerbai Wadia HLospital for Children,Acharya Donde marg , Parel, Mumbai
Mumbai
MAHARASHTRA
400012
India 
Phone  9820042059  
Fax    
Email  utture.alpana@gmail.com  
 
Source of Monetary or Material Support  
none 
 
Primary Sponsor  
Name  Bai Jerbai Wadia Hospital for Children 
Address  Bai Jerbai Wadia Hospital for Children, Acharya Donde Marg, Parel, Mumbai, Maharashtra, 400012 
Type of Sponsor  Research institution 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Alpana Utture  Bai Jerbai Wadia Hospital for Children  Division of Neonatology, 2nd floor, Bai Jerbai Wadia hospital for children, Acharya Donde Marg Parel
Mumbai
MAHARASHTRA 
02224197200

utture.alpana@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
BJWHC IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  , (1) ICD-10 Condition: P018||Newborn affected by other maternalcomplications of pregnancy, (2) ICD-10 Condition: K638||Other specified diseases of intestine,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  early feeding  early feeding with mothers own milk or pasteurized donor human milk will be started within 24 hours of life as early as 6 hours @ 20ml per kg per day and increased daily by 20 ml per kg per day till bay reaches 150 ml/kg/day and sustain this volume for 3 days 
Comparator Agent  late feeding  late feeding will start at 48 hours of life at 20ml per kg per day and remail same for next 48 hours and then increased by 20 ml per per day till baby reaches 150 ml/kg/day and sustain this volume for 3 dyas 
 
Inclusion Criteria  
Age From  1.00 Day(s)
Age To  2.00 Day(s)
Gender  Both 
Details  Preterm babies with abnormal dopplers will be randomized within 6 hours of life 
 
ExclusionCriteria 
Details  1. Neonates with major congenital malformations including gastrointestinal obstruction
2. Babies with known chromosomal abnormality or with dysmorphic features
3. Neonates with severe birth asphyxia (APGAR <4 at 5 min of life with cord/within 1 hour of life pH <7)
4. Twin to twin transfusion
5. Neonates requiring intrauterine transfusion or exchange transfusion
6. Significant multi-organ failure prior to trial entry
7. Inotropic support prior to trial entry
8. Already received any enteral feeding
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
Time taken to achieve full enteral feeds  till the hospital stay 
 
Secondary Outcome  
Outcome  TimePoints 
1. Incidence of NEC
2. Day of regaining birthweight
3. Duration of Parenteral nutrition
4. Duration of hospitalization
5. Incidence of late onset sepsis


 
Till the hospital stay 
 
Target Sample Size   Total Sample Size="120"
Sample Size from India="120" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   25/12/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="1"
Days="30" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   not yet published 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary   This study is being conducted in preterm babies born with antenatal abnormal dopplers . After randomization these babies will be divided into two groups , early and late feeding groups  and will be fed according to the protocol till they reach a full feeds of 150 ml per kg per day. during their hospital stay , babies will be monitored for signs of feed intolerance and action will be taken accordingly.Time taken to reach full feed will be taken as primary outcome . And ,incidence of NEC, day of regaining birthweight, duration of Parenteral nutrition, duration of hospitalization and incidence of late onset sepsis will be the secondary outcome.

 

 

 
Close